Medical Management : For patients with documented osteoporosis or high fracture risk, pharmacologic bone-protective therapy may be indicated regardless of GLP-1 use
Loss of NF1 gene function, mutations in TP53 or CDKN2A/B, and expression of SOX10, H3K27me3 loss, or PRC2 complex mutations may support the diagnosis of MPNST (Reuss et al., 2020)
Abu-Huwaij R, Zidan AN
The thioredoxin (Trx)-based system is another crucial antioxidant pathway in melanocytes, composed of Trx, thioredoxin reductase (Trx-R), and NADPH
Int J Mol Sci 14(11):2151321524 Zhu H, Zhang Y, Shi Z et al
Topical Glutathione: It may cause skin sensitivity to some individuals or when paired with other active ingredients